Covington advised OrbiMed on the deal. OrbiMed acted as the lead investor in a $400 million senior secured term loan facility provided to Caris Life Sciences, a...
You must be a Standard 1 Year member to access this content.
Covington represented the underwriters on the deal. Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders,...
You must be a Standard 1 Year member to access this content.
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
You must be a Standard 1 Year member to access this content.
